Staley Capital Advisers »

Corcept Therapeutics Incorporated shares owned by Staley Capital Advisers

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Staley Capital Advisers from 13F filings

Historical chart of Staley Capital Advisers investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Staley Capital Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Staley Capital Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $230k 2.8k 83.11
2025-06-30 $203k 2.8k 73.40
2025-03-31 $248k 2.2k 114.22

More positions owned by Staley Capital Advisers

Microsoft Corporation (MSFT)
iSHARES RUSSELL 1000 GROWTH Etf (IWF)
Alphabet Inc Class C cs (GOOG)
JPMorgan Chase & Co. (JPM)
Qualcomm (QCOM)
Berkshire Hathaway (BRK.B)
Amazon (AMZN)
Boeing Company (BA)
Spdr Gold Shares Etf (GLD)
Chevron Corporation (CVX)
J.M. Smucker Company (SJM)
Fiserv (FI)
FedEx Corporation (FDX)
International Flavors & Fragrances (IFF)
Pfizer (PFE)

View all positions for Staley Capital Advisers

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated